 | | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 Since the new technique can help track disease progress, the researchers hope that it can be used to monitor the effectiveness of potential drug treatments for JMML and other disorders.
"Identifying populations of cells by their responses to specific stimuli will facilitate our ability to assess the efficacy of specific agents in relevant subsets with increased precision," senior-co-author Mignon Loh, an associate professor of clinical pediatrics at the University of California, San Francisco, said in the release.
"In an era of using increasingly sophisticated targeted agents, we hope that these studies will allow investigators to more fully appreciate the specificities of their therapies," said Loh.
Text Continues Below
More information
The American Cancer Society has more about childhood leukemia.
Page: << Prev | 1 | 2
-- Krisha McCoy
|
.gif)
